Skip to main content
Article
Fingolimod (FTY720) as an Acute Rescue Therapy for Intraocular Inflammatory Disease
Arch Ophthalmol
  • Ramesh S Ayyala
  • Lynn E Harman
  • B Michelini-Norris
  • Leo E Ondrovic
  • Edward M Haller, University of South Florida
  • Curtis E Margo
  • Scott X Stevens
Document Type
Article
Publication Date
2-1-1999
Digital Object Identifier (DOI)
https://doi.org/10.1001/archopht.117.2.233
Abstract
Objectives To compare the inflammatory reaction associated with the insertion of silicone and polypropylene endplates and endplates made of a new biocompatible polymer, Vivathane, in the rabbit subconjunctival space. Methods Similar-sized endplates made of 3 different biomaterials were sutured to the sclera in the superotemporal quadrant of the rabbit eye. Thirty eyes of 15 albino New Zealand rabbits were randomly assigned to the 3 groups. Conjunctival vascular hyperemia was graded in a masked fashion among groups. At the end of 3 weeks, the enucleated eyes were examined histologically and using scanning electron microscopy. Results Polypropylene and Vivathane were associated with significantly more inflammation in clinical observations and based on histological grading. Silicone was associated with the least amount of inflammation. Three polypropylene and 1 Vivathane plate were extruded between the second and third week. Conclusions Silicone is the most inert of the 3 materials tested. Inflammation associated with biomaterials may contribute to the failure of the glaucoma drainage devices. Clinical Relevance Bleb inflammation may be related to the biomaterial being used as the endplate. Endplates should be handled carefully during surgery to avoid creating rough spots.
Comments

Additional Authors: Haller E, Margo CE, Stevens SX

Rights Information
Default Rights Statement
Citation / Publisher Attribution

Arch Ophthalmol, v. 117, issue 2, p. 233-236

Citation Information
Ramesh S Ayyala, Lynn E Harman, B Michelini-Norris, Leo E Ondrovic, et al.. "Fingolimod (FTY720) as an Acute Rescue Therapy for Intraocular Inflammatory Disease" Arch Ophthalmol Vol. 117 Iss. 2 (1999) p. 233 - 236
Available at: http://works.bepress.com/edward_haller/33/